Search Results - "Arrichiello, Gianluca"
-
1
Beyond N staging in colorectal cancer: Current approaches and future perspectives
Published in Frontiers in oncology (18-07-2022)“…Traditionally, lymph node metastases (LNM) evaluation is essential to the staging of colon cancer patients according to the TNM (tumor-node-metastasis) system…”
Get full text
Journal Article -
2
Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives
Published in Exploration of targeted anti-tumor therapy (22-06-2022)“…Biliary tract cancer (BTC) is an aggressive tumor characterized by a poor prognosis. In the latest years, targetable genetic alterations have been discovered…”
Get full text
Journal Article -
3
How I treat anal squamous cell carcinoma
Published in ESMO open (01-09-2020)“…Squamous cell carcinoma of the anus (SCCA) is a rising health issue, strongly related to other relevant medical conditions such as (HIV) and human…”
Get full text
Journal Article -
4
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening?
Published in Cancer treatment and research communications (2021)“…Immunotherapy has recently become a major treatment modality for several types of solid tumours, achieving remarkable and long-lasting remissions. In…”
Get full text
Journal Article -
5
Epigenetic Regulation in Melanoma: Facts and Hopes
Published in Cells (Basel, Switzerland) (11-08-2021)“…Cutaneous melanoma is a lethal disease, even when diagnosed in advanced stages. Although recent progress in biology and treatment has dramatically improved…”
Get full text
Journal Article -
6
Overcoming immune-resistance in laryngeal cancer: a case report of the abscopal effect and nivolumab beyond progression
Published in Immunotherapy (01-10-2022)“…The abscopal effect is defined as the systemic regression of distant neoplastic lesions induced by localized treatment. Although the first case reports date…”
Get full text
Journal Article -
7
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience
Published in Cancers (08-10-2019)“…Tumor heterogeneity represents a possible cause of error in detecting predictive genetic alterations on tumor tissue and can be overcome by testing alterations…”
Get full text
Journal Article -
8
Abstract 2627: Inhibition of TGFβ in colorectal cancer cells is associated with a compensatory activation of AXL and p38 MAPK signaling pathways
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract According to the consensus molecular subtypes (CMS), almost 23% of human colorectal cancer (CRC) are classified in the CMS4 group, characterized by a…”
Get full text
Journal Article -
9
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer
Published in Targeted oncology (01-11-2022)“…Background The combination of trifluridine-tipiracil and bevacizumab was compared with trifluridine-tipiracil monotherapy in a randomized, open-label, phase II…”
Get full text
Journal Article -
10
Multi-Omic Approaches in Colorectal Cancer beyond Genomic Data
Published in Journal of personalized medicine (18-01-2022)“…Colorectal cancer (CRC) is one of the most frequent tumours and one of the major causes of morbidity and mortality globally. Its incidence has increased in…”
Get full text
Journal Article